Objective:To investigate the association of impaired fasting glucose(IFG) and fasting blood glucose(FBG) levels with the risk of cardiovascular disease based on the latest 10-year atherosclerotic cardiovascular disease(ASCVD) risk assessment model. Methods:The study enrolled 362 subjects with FBG measurement results from those patients who visited our internal medicine outpa-tient and wards of our hospital,and those who came to our hospital for physical examination,between July 2015 and April 2017,a-mong which 87 subjects in IFG status. The IFG is defined according to the definition of diabetes reported by the World Health Or-ganization in 1999(6.1 mmol/L≤FBG<7.0 mmol/L). The estimated 10-year ASCVD risk score was calculated through the computa-tional equations given by the American Heart Association(ACC/AHA) Practice Guidelines Working Group. Results:Compared with people with normal glucose metabolism,statistical analysis showed that IFG people had higher body mass index,systolic blood pres-sure,diastolic blood pressure,FBG,and triglyceride levels(P<0.05). Multivariate logistic regression indicated that,the IFG people was significantly associated with an increased risk of at 10-year ASCVD(≥7.5%)[OR:95%CI=4.41(1.78-10.93),P=0.001] compared to people with normal fasting glucose. FBG level was closely related to 10-year ASCVD risk score. With the increase of FBG level,the 10-year ASCVD risk gradually increased,especially when the FBG was higher than 5.7 mmol/L,the 10-year ASCVD risk was signifi-cantly increased(≥7.5%). Conclusion:Based on the latest published 10-year ASCVD risk assessment equation,the study has found that both IFG and FBG levels are significantly associated with an increased risk of cardiovascular disease.